KALARIS THERAPEUTICS, INC. Restructuring Reserve
KALARIS THERAPEUTICS, INC. (KLRS) had Restructuring Reserve of $101.00 thousand as of 2024-12-31, per its 10-K filed 2025-03-07.
Financial Statements › Balance Sheet › Liabilities
us-gaap:RestructuringReserve · last filed 2025-03-07
- 2024-12-31: Restructuring Reserve $101.00K.
- 2024-09-30: Restructuring Reserve $120.00K.
- 2024-06-30: Restructuring Reserve $812.00K.
- 2024-03-31: Restructuring Reserve $1.71M.
| Period end | Restructuring Reserve |
|---|---|
| 2024-12-31 | $101.00K 10-K · filed 2025-03-07 |
| 2024-09-30 | $120.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $812.00K 10-Q · filed 2024-08-09 |
| 2024-03-31 | $1.71M 10-Q · filed 2024-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |